Stage IIIB/C
Showing 1 - 25 of >10,000
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction
Not yet recruiting
- Non-small Cell Lung Cancer
- NGS and ctDNA-MRD detection
-
Changsha, Hunan, ChinaDepartment of Thoracic Surgery, Second Xiangya Hospital of Centr
Apr 18, 2023
NSCLC (NSCLC) Trial (Sotorasib, Pembrolizumab)
Not yet recruiting
- Non-Small Cell Lung Cancer (NSCLC)
- (no location specified)
Jun 26, 2023
Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
-
Amsterdam, NH, NetherlandsAntoni van Leeuwenhoek ziekenhuis
Feb 11, 2022
Melanoma, Lymph Node Cancer Trial in Pittsburgh (CMP-001, Nivolumab)
Active, not recruiting
- Melanoma
- Lymph Node Cancer
- CMP-001
- Nivolumab
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 15, 2022
Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma Trial in Buffalo (Recombinant Human Hsp110-gp100
Terminated
- Recurrent Melanoma
- +3 more
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine
- Laboratory Biomarker Analysis
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID
Active, not recruiting
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
- +2 more
- Dabrafenib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 9, 2022
Melanoma Trial in Wollstonecraft, Cairns (tigilanol tiglate)
Recruiting
- Melanoma
- tigilanol tiglate
-
Wollstonecraft, New South Wales, Australia
- +2 more
Oct 6, 2022
Melanoma (Skin) Trial in Strasbourg (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Cryotherapy, Ipilimumab Injection)
Completed
- Melanoma (Skin)
- Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
- +2 more
-
Strasbourg, FranceClinique Dermatologique/Radiologie Interventionnelle/Urologie/Gy
Apr 29, 2022
Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)
Active, not recruiting
- Melanoma
- Dabrafenib
- +2 more
-
Sydney, New South Wales, Australia
- +2 more
Apr 4, 2022
Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)
Recruiting
- Lung Cancer
- AMG 510
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
Melanoma Trial in Pittsburgh (drug, biological, other)
Recruiting
- Melanoma
- Vidutolimod (CMP-001)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 25, 2022
Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C
Active, not recruiting
- Prostate Adenocarcinoma
- +9 more
- Hyperpolarized Carbon C 13 Pyruvate
- Magnetic Resonance Spectroscopic Imaging
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium
Recruiting
- Advanced Malignant Solid Neoplasm
- +22 more
- TRPV6 Calcium Channel Inhibitor SOR-C13
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)
Active, not recruiting
- EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
- Atezolizumab
- +4 more
-
Großhansdorf, Germany
- +17 more
Jan 12, 2023
AIDS-Related Anal Carcinoma, Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma Trial in United States (drug, radiation,
Recruiting
- AIDS-Related Anal Carcinoma
- +22 more
- Capecitabine
- +4 more
-
San Francisco, California
- +8 more
Jan 27, 2023
Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic
Recruiting
- Locally Advanced Intrahepatic Cholangiocarcinoma
- +5 more
- Bintrafusp Alfa
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,
Terminated
- Rectal Mucinous Adenocarcinoma
- +8 more
- Capecitabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,
Recruiting
- Advanced Bladder Carcinoma
- +34 more
- Atezolizumab
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston
Terminated
- Resectable Lung Non-Small Cell Carcinoma
- +10 more
- Bintrafusp Alfa
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jul 27, 2022
Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)
Recruiting
- Gastric Cancer Stage IIIB-IIIC
- Pembrolizumab + SOX
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 7, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +5 more
- Atezolizumab
- +3 more
-
Jacksonville, Florida
- +2 more
Oct 21, 2022
Patients With Colorectal Cancer, the MiRDA-C Study
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Biospecimen Collection
- Electronic Health Record Review
-
Gilbert, Arizona
- +8 more
Aug 16, 2022